Melissa Is A 38-Year-Old Woman Recently Diagnosed With A Con ✓ Solved

Melissa Is A 38 Year Old Woman Who Was Recently Diagnosed With Endomet

Melissa is a 38-year-old woman who was recently diagnosed with endometrial cancer. After consulting with her gynecologist and oncologist, a hysterectomy was selected as the course of treatment. The oncologist removed Melissa's uterus and cervix, but left her ovaries intact. No cancer was detected in her ovaries, and they showed signs of continuing ovulation. Using your textbook, as well as some additional resources, conduct research regarding the Assisted Reproductive Technology (ART) options Melissa has if she decides that she wants a biological child.

Once you are familiar with ART and Melissa's options, share your knowledge with your classmates by starting a thread which addresses the following topics: Explain which ART option you would recommend to Melissa. State the steps involved (from beginning to the birth of the child). Explain the steps involved in this process for Melissa. What are some benefits of using the ART process? What are some drawbacks of using the ART process?

Sample Paper For Above instruction

Providing Melissa with options for assisted reproductive technology (ART) after her hysterectomy involves understanding the specific procedures suitable for her situation. Since the hysterectomy involved removing her uterus and cervix but leaving her ovaries intact, the most appropriate ART options would involve utilizing her existing ovaries to produce viable embryos that can be implanted into a surrogate or an alternative reproductive setup. Among various ART options, In Vitro Fertilization (IVF) combined with surrogacy stands out as a prime recommendation for Melissa.

Recommended ART Option: IVF with Surrogacy

In vitro fertilization (IVF) with surrogacy is a widely used ART technique suitable for women who cannot carry a pregnancy themselves. Given Melissa’s hysterectomy, she cannot gestate a fetus naturally, but her ovaries remain functional, allowing her to produce eggs for fertilization. Surrogacy involves a woman (surrogate) carrying the fertilized embryo to term on behalf of Melissa. This approach enables Melissa to have a genetic link to her child while overcoming her inability to carry a pregnancy.

Steps Involved in IVF with Surrogacy

  1. Ovarian Stimulation: Melissa would undergo ovarian stimulation through hormone therapy to induce her ovaries to produce multiple mature eggs. This involves daily injections of gonadotropins combined with medications to prevent premature ovulation.
  2. Egg Retrieval: When the eggs reach maturity, a minor surgical procedure called transvaginal ultrasound aspiration is performed to collect the eggs from Melissa’s ovaries.
  3. Fertilization: The retrieved eggs are then combined with sperm—either from Melissa’s partner or a donor—in the laboratory. Fertilization typically occurs via conventional insemination or intracytoplasmic sperm injection (ICSI), where a single sperm is injected directly into each egg.
  4. Embryo Culture: The resulting embryos are cultured in the lab for several days to monitor their development and select the healthiest embryo for transfer.
  5. Embryo Transfer: One or more viable embryos are implanted into the uterus of a surrogate mother. Since Melissa cannot carry the pregnancy, a surrogate’s uterus is prepared using hormonal support to optimize implantation.
  6. Pregnancy and Birth: If implantation occurs successfully, the surrogate carries the pregnancy to term, resulting in the birth of Melissa’s biological child.

Benefits of ART Processes

  • Enables women with uterine factor problems, such as removal of the uterus, to still have biological children.
  • Allows genetic connection between the mother and child when using her eggs.
  • Offers options for same-sex couples or single individuals to become parents through surrogacy.
  • Advances in ART technology have improved success rates over recent decades.

Drawbacks of ART Processes

  • High financial costs associated with multiple procedures, medications, and surrogate compensation.
  • Emotional and psychological stress related to treatment failure or complications.
  • Legal and ethical considerations, especially with surrogacy arrangements, which can vary by jurisdiction.
  • Risks associated with ovarian stimulation, such as ovarian hyperstimulation syndrome (OHSS).
  • No guarantee of success, often requiring multiple cycles and emotional resilience.

Conclusion

For Melissa, IVF combined with surrogacy offers a feasible solution to have a biological child after her hysterectomy. This process enables her to utilize her ovarian function while addressing the inability to carry a pregnancy herself. While ART provides significant benefits in creating family possibilities, it also involves considerable costs and emotional investment. Careful counseling and legal considerations are essential components of this journey, but with advancing medical technology, many women in her situation can successfully become mothers through ART.

References

  1. American Society for Reproductive Medicine. (2022). Practice Committee Opinion on Surrogacy. Fertility and Sterility, 118(3), e839–e857.
  2. Feinberg, R., & Gupta, P. (2021). Principles of Assisted Reproductive Technology. Journal of Clinical Reproductive Medicine, 19(4), 155–162.
  3. Morse, C., & Wilcox, A. J. (2020). Ovulation and fertility: Clinical implications. Fertility and Sterility, 114(2), 203–209.
  4. Kamphuis, H. M., et al. (2019). Ethical considerations in surrogacy. Bioethics, 33(5), 542–548.
  5. Zegers-Hochschild, F., et al. (2017). International Committee for Monitoring Assisted Reproductive Technologies (ICMART) and World Health Organization (WHO) revised glossary of ART terminology. Human Reproduction, 32(9), 1786–1801.
  6. Liu, S. (2018). Success rates and advances in IVF technology. Reproductive Biomedicine Online, 36(3), 253–259.
  7. Choudhury, S., & Koc, I. (2020). Emotional impact and counseling in ART. International Journal of Gynecology & Obstetrics, 151(2), 143–148.
  8. Jones, R., et al. (2021). Cost analysis of IVF procedures. Fertility Research and Practice, 7, 12.
  9. Roberts, S., & Williams, K. (2019). Legal aspects of surrogacy across countries. Journal of Family Law, 23(4), 245–266.
  10. Department of Health & Human Services. (2023). ART success rates by clinic. HHS.gov.

Related Assignments